A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection-Reference-Cited by-同舟云学术

A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection

Published:2020-10-04 Issue:2 Volume:44 Page:358-366
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J of Inher Metab Disea

Author:

Koga Yasutoshi¹^ORCID,Povalko Nataliya¹²,Inoue Eisuke³,Ishii Akiko⁴,Fujii Katsunori⁵,Fujii Tatsuya⁶,Murayama Kei⁷,Mogami Yukiko⁸,Hata Ikue⁹,Ikawa Masamichi¹⁰¹¹,Fukami Kei¹²,Fukumoto Yoshihiro¹³,Nomura Masatoshi¹⁴,Ichikawa Kazuki¹⁵,Yoshida Kaori¹⁵

Affiliation:

1. Department of Pediatrics and Child Health Kurume University School of Medicine Kurume Japan

2. Institute of Fundamental Medicine and Biology, Open Lab Gene and Cell Technology Kazan Federal University Kazan Russian Federation

3. Showa University Research Administration Center, Showa University Tokyo Japan

4. Department of Neurology Tsukuba University School of Medicine Tsukuba Japan

5. Department of Pediatrics Chiba University Graduate School of Medicine Chiba Japan

6. Department of Pediatrics Shiga Medical Center for Children Moriyama Japan

7. Department of Metabolism Center for Medical Genetics, Chiba Children's Hospital Chiba Japan

8. Department of Neurology Osaka Women's and Children's Hospital Izumi Japan

9. Department of Pediatrics Fukui University School of Medicine Fukui Japan

10. Department of Advanced Medicine for Community Healthcare, Faculty of Medical Sciences University of Fukui Fukui Japan

11. Biomedical Imaging Research Center, University of Fukui Fukui Japan

12. Division of Nephrology, Department of Medicine Kurume University School of Medicine Kurume Japan

13. Division of Cardiovascular Medicine, Department of Internal Medicine Kurume University School of Medicine Kurume Japan

14. Division of Endocrinology and Metabolism, Department of Internal Medicine Kurume University School of Medicine Kurume Japan

15. Medical and Biological Laboratories Co., Ltd., Ina Laboratory Ina Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jimd.12317

Reference25 articles.

1. Clinical presentation of mitochondrial disorders in childhood

2. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease

3. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study

4. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies

5. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome;Scientific Reports;2024-05-21

2. Drastic fall of growth differentiation factor 15 in influenza encephalopathy;Pediatrics International;2024-01

3. Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation;Brain Pathology;2023-08-03

4. A brief introduction to the history of mitochondrial research in Japan;Mitochondrial Communications;2023

5. Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies;Journal of Neuromuscular Diseases;2022-03-01